ImpactOS
See an example

Takeda Pharmaceuticals International AG

Companies and groups · Switzerland

In these lists: Medicines

Declared lobbying cost
€1,000,000 – €1,249,999 Financial year 04/2024-03/2025
Commission meetings
4
Full-time staff on EU lobbying
1.75
European Parliament access passes
3
Registered since
17 Sept 2015
Public records onlyWhat this means

Every profile, record and figure comes from documents published by EU institutions, national authorities, courts, ethics bodies, the EU Transparency Register or established news outlets. We use no leaks, private data or anonymous tips. AI helps us gather and cross-check sources but never decides anyone's guilt: each record keeps its exact legal status and links to its source, so you can check it yourself

Registering is a legal transparency duty, not a sign of wrongdoing. Budgets and meetings show access, not influence on any particular decision. Register figures as declared on 30 Jun 2026

Fields of interest

Business and industry, Competition, Consumers, Customs, Digital economy and society, Economy, finance and the euro, Environment, External relations, Foreign affairs and security policy, Humanitarian aid and civil protection, Institutional affairs, Public health, Research and innovation, Single market, Taxation, Trade

Medicines and food topics they name

EU medicines law, Vaccines

EU laws and policies they declare following1
  • We follow EU initiatives, policies and legislative files related to our Pharmaceuticals and Vaccines businesses. This includes topics such as R&D and clinical trials, data protection, relevant pharma…

Meetings with the Commission

Meetings with Commissioners or their Cabinets since 1 December 2024, as the Commission publishes them

  1. With the Cabinet

    Olivér Várhelyi

    EUCOPE - Strasbourg

    Published record
  2. With the Commissioner

    Olivér Várhelyi

    All pressing portfolio topics

    Published record
  3. With the Cabinet

    Olivér Várhelyi

    All pressing portfolio topics

    Published record
  4. With the Cabinet

    Ursula von der Leyen

    the EU biopharmaceutical landscape

    Published record

Official entries

Checked against sources on 11 Nov 2026